MX2016015185A - Sistema terapeutico transdermico que contiene aceite de lavanda. - Google Patents

Sistema terapeutico transdermico que contiene aceite de lavanda.

Info

Publication number
MX2016015185A
MX2016015185A MX2016015185A MX2016015185A MX2016015185A MX 2016015185 A MX2016015185 A MX 2016015185A MX 2016015185 A MX2016015185 A MX 2016015185A MX 2016015185 A MX2016015185 A MX 2016015185A MX 2016015185 A MX2016015185 A MX 2016015185A
Authority
MX
Mexico
Prior art keywords
transdermal therapeutic
lavender oil
system containing
therapeutic system
tts
Prior art date
Application number
MX2016015185A
Other languages
English (en)
Inventor
Thomas Hille
Petra Botzem
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of MX2016015185A publication Critical patent/MX2016015185A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0246—Adhesive bandages or dressings characterised by the skin-adhering layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production
    • A61M2207/10—Device therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se relaciona con sistemas terapéuticos transdérmicos (STT) que contienen aceite de lavanda como sustancia activa y con su uso en la prevención y/o tratamiento de excitación, alteraciones del sueño, ansiedad y nerviosismo, en particular de excitación en depresión por ansiedad; la invención también se relaciona con métodos para producir estos STT, en cuyos métodos, dichos STT son producidos por medio del uso de materiales de soporte a partir de componentes fibrosos y son cargados con sustancia activa por medio de un método de impresión.
MX2016015185A 2014-05-20 2015-05-08 Sistema terapeutico transdermico que contiene aceite de lavanda. MX2016015185A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14169037.0A EP2946775A1 (de) 2014-05-20 2014-05-20 Lavendelöl enthaltendes transdermales therapeutisches System
PCT/EP2015/000955 WO2015176801A1 (de) 2014-05-20 2015-05-08 Lavendelöl enthaltendes transdermales therapeutisches system

Publications (1)

Publication Number Publication Date
MX2016015185A true MX2016015185A (es) 2017-03-03

Family

ID=50735941

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016015185A MX2016015185A (es) 2014-05-20 2015-05-08 Sistema terapeutico transdermico que contiene aceite de lavanda.

Country Status (9)

Country Link
US (1) US20170080038A1 (es)
EP (2) EP2946775A1 (es)
JP (2) JP7063537B2 (es)
KR (1) KR20170009921A (es)
CN (1) CN107073058A (es)
CA (1) CA2949568C (es)
MX (1) MX2016015185A (es)
RU (1) RU2695785C2 (es)
WO (1) WO2015176801A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10682487B2 (en) * 2015-02-08 2020-06-16 Cpap Infusion, Llc Scent delivery adaptor for CPAP
DE102019117310A1 (de) 2019-06-27 2020-12-31 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Wirkstoffverabreichungssystemen mittels Tampondruckverfahren

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727232A1 (de) * 1987-08-14 1989-02-23 Lohmann Therapie Syst Lts Verfahren zur herstellung einer darreichungs- und/oder dosierungsform fuer arzneimittelwirkstoffe
JP2500193B2 (ja) 1993-07-07 1996-05-29 ニイガタプラントサービス株式会社 ケ―キ等に対するフィルムの巻付け装置
DE4400769C2 (de) 1994-01-13 1996-07-18 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zur Herstellung einer flächigen Darreichungsform mit einer Arzneimittelwirkstoffe enthaltenden Zubereitung
GB9720479D0 (en) * 1996-10-23 1997-11-26 Le Gall Madeleine Dressing
WO2000056290A1 (de) * 1999-03-18 2000-09-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches system und verfahren zu seiner herstellung
DE19912477A1 (de) 1999-03-19 2000-09-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System und Verfahren zu seiner Herstellung
JP2001064193A (ja) * 1999-06-12 2001-03-13 Saiji Okada ラベンダー湿布
US6974588B1 (en) * 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
DE10246377B4 (de) * 2002-10-04 2007-01-11 Beiersdorf Ag Verfahren zur Herstellung von Pflastersystemen mit dotierten Trägermaterialien als Reservoir
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
DE102004048716A1 (de) 2004-10-06 2006-04-20 Dr. Willmar Schwabe Gmbh & Co. Kg Verwendung von Lavendelöl zur Prophylaxe und Behandlung von Neurasthenie, Somatisierungsstörungen und von anderen stress-assoziierten Erkrankungen
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
DE102005033543A1 (de) 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
GT200600396A (es) * 2005-09-07 2007-04-23 Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales
US20110300198A1 (en) 2010-06-03 2011-12-08 Amos Nussinovitch Hydrocolloid - essential oil patches
CN102327336B (zh) * 2011-09-19 2013-01-16 宁波浙成科技咨询有限公司 一种外用安眠贴
CN103316078B (zh) * 2013-06-18 2015-01-14 安徽万邦医药科技有限公司 一种舒眠降温贴剂及其制备方法

Also Published As

Publication number Publication date
RU2695785C2 (ru) 2019-07-26
KR20170009921A (ko) 2017-01-25
BR112016026599A2 (pt) 2017-08-15
JP2021020959A (ja) 2021-02-18
US20170080038A1 (en) 2017-03-23
WO2015176801A1 (de) 2015-11-26
EP3145501A1 (de) 2017-03-29
JP2017522269A (ja) 2017-08-10
CN107073058A (zh) 2017-08-18
RU2016149799A (ru) 2018-06-21
WO2015176801A8 (de) 2016-12-08
EP3145501C0 (de) 2024-02-21
EP3145501B1 (de) 2024-02-21
JP7063537B2 (ja) 2022-05-09
CA2949568A1 (en) 2015-11-26
RU2016149799A3 (es) 2018-10-25
CA2949568C (en) 2023-12-12
EP2946775A1 (de) 2015-11-25

Similar Documents

Publication Publication Date Title
CL2015002529A1 (es) Compuestos de tetrahidropirrolotiazina
CL2015002123A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos
TW201613902A (en) Difluoropyrrolidines as orexin receptor modulators
ECSP17018120A (es) Triazolopirazinonas como inhibidores de pde1
CL2016001595A1 (es) Moduladores de tetrahidropiridopirazinas de gpr6.
CL2016002157A1 (es) Anticuerpos anti-cd38 para el tratamiento de leucemia linfoide aguda
CL2017002719A1 (es) Imidazopirazinonas como inhibidores de pde1
MX2016004540A (es) Tiazolopirimidinonas como moduladores de la actividad de receptores de n-metil-d-aspartato (nmda).
MX2019002190A (es) Uso de pridopidina para tratar distonías.
ECSP16061208A (es) Quinazolin-thf-aminas como inhibidores de pde1
DOP2016000263A (es) Quinazolin-thf-aminas halogenadas como inhibidores de pde1
MX2016015185A (es) Sistema terapeutico transdermico que contiene aceite de lavanda.
MX361770B (es) Método para la preparación de 1-alquil-3-difluorometil-5-fluor-1h- pirazol-4-carbaldehídos y 1-alquil-3-difluorometil-5-fluor-1h-pira zol-4-carboxilatos.
ECSP16071574A (es) Hexahidrofuropirroles como inhibidores de pde1
MX2014004773A (es) Emulsiones que contienen emulsionantes cationicos polimericos, sustancia y proceso.
MX2019014682A (es) Aparatos, sistemas y metodos para mejorar los soportes estructurales verticales.
MX2017013156A (es) Metodos para tratar enfermedades.
AU2015242879A1 (en) Melatonin secretion regulator, and method for regulating melatonin secretion
MX2018003040A (es) Metodos para el tratamiento de formas recurrentes de esclerosis multiple.
TN2011000520A1 (en) Chromane derivatives as trpv3 modulators